Toll-like receptors in systemic autoimmune disease.
Toll-like receptors in systemic autoimmune disease.
复制标题
DOI:
10.1038/nri1957
复制
发表时间:
2006-11
期刊:
影响因子:
--
通讯作者:
Marshak-Rothstein A
中科院分区:
文献类型:
--
作者:
Marshak-Rothstein A
Autoreactive B cells can be activated effectively in vitro by endogenous DNA or RNA, as well as by DNA- or RNA-binding proteins, through a mechanism that depends on the B-cell receptor and Toll-like receptor 7 (TLR7) and/or TLR9. B-cell responses to RNA-associated autoantigens are markedly increased by type I interferons (IFNs). Similarly, it seems that TLR7 and TLR9 have important roles in the activation of plasmacytoid dendritic cells, through a mechanism that depends on the low-affinity receptor for IgG (FcγRIIa; also known as CD32), leading to the production of large amounts of type I IFNs. Mice that inherit the Y-chromosome-linked autoimmune accelerator (Yaa) mutation express twice the normal amount of TLR7 and are hyper-responsive to TLR7 ligands. The increased amount of TLR7 might account for the role of TLR7 in the acceleration of autoimmune disease in these mice. TLR9-deficient autoimmune-prone mice have a decreased capacity to produce antibodies specific for double-stranded DNA or nucleosomes, but they produce normal or increased amounts of antibodies specific for RNA-associated autoantigens. Nevertheless, TLR9 deficiency can lead to exacerbation of clinical disease in some animal models of systemic lupus erythematosus. TLR7-deficient autoimmune-prone mice have a decreased capacity to produce antibodies specific for RNA-associated autoantigens. In contrast to TLR9 deficiency, TLR7 deficiency does not lead to exacerbated clinical disease. In addition to DNA and RNA, other endogenous TLR ligands that are released from dead or dying cells or are released as a result of tissue injury have been found either to promote or to downregulate chronic inflammatory conditions. Toll-like receptors are well known as sensors of microorganisms, but they can also sense endogenous molecules. This article describes when this might occur and how it might activate autoreactive B cells and plasmacytoid dendritic cells in systemic autoimmune disease. Toll-like receptors (TLRs) have a crucial role in the early detection of pathogen-associated molecular patterns and the subsequent activation of the adaptive immune response. Whether TLRs also have an important role in the recognition of endogenous ligands has been more controversial. Numerous in vitro studies have documented activation of both autoreactive B cells and plasmacytoid dendritic cells by mammalian TLR ligands. The issue of whether these in vitro observations translate to an in vivo role for TLRs in either the initiation or the progression of systemic autoimmune disease is a subject of intense research; data are beginning to emerge showing that this is the case.
登录
查看更多内容
影响因子:
32.4
作者:
Berland, Robert;Fernandez, Luis;Imanishi-Kari, Thereza
通讯作者:
Imanishi-Kari, Thereza
影响因子:
4.4
作者:
Caricchio, R;McPhie, L;Cohen, PL
通讯作者:
Cohen, PL
DOI:
10.1084/jem.20050338
发表时间:
2005-07-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Christensen SR;Kashgarian M;Alexopoulou L;Flavell RA;Akira S;Shlomchik MJ
通讯作者:
Shlomchik MJ
DOI:
10.1084/jem.20021553
发表时间:
2003-03-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bennett L;Palucka AK;Arce E;Cantrell V;Borvak J;Banchereau J;Pascual V
通讯作者:
Pascual V
影响因子:
--
作者:
Andrade, F;Casciola-Rosen, LA;Rosen, A
通讯作者:
Rosen, A